William G. Harris - Aug 26, 2022 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role
Director
Signature
/s/ Anish Bhatnagar, Attorney-in-Fact
Stock symbol
SLNO
Transactions as of
Aug 26, 2022
Transactions value $
$0
Form type
4
Date filed
10/14/2022, 06:44 PM
Previous filing
Oct 14, 2022
Next filing
May 26, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SLNO Common Stock 8.9K Aug 26, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SLNO Stock option (right to buy) 93 Aug 26, 2022 Common Stock 93 $535.50 Direct F2, F3
holding SLNO Stock option (right to buy) 66 Aug 26, 2022 Common Stock 66 $135.00 Direct F2, F3
holding SLNO Stock option (right to buy) 66 Aug 26, 2022 Common Stock 66 $349.50 Direct F2, F3
holding SLNO Stock option (right to buy) 361 Aug 26, 2022 Common Stock 361 $90.00 Direct F2, F3
holding SLNO Stock option (right to buy) 601 Aug 26, 2022 Common Stock 601 $54.00 Direct F2, F3
holding SLNO Stock option (right to buy) 1.06K Aug 26, 2022 Common Stock 1.06K $30.60 Direct F3, F4
holding SLNO Stock option (right to buy) 823 Aug 26, 2022 Common Stock 823 $39.45 Direct F3, F4
holding SLNO Stock option (right to buy) 635 Aug 26, 2022 Common Stock 635 $51.15 Direct F3, F4
holding SLNO Stock option (right to buy) 2.67K Aug 26, 2022 Common Stock 2.67K $33.60 Direct F3, F4
holding SLNO Stock option (right to buy) 2.12K Aug 26, 2022 Common Stock 2.12K $15.30 Direct F3, F4
holding SLNO Stock option (right to buy) 2.67K Aug 26, 2022 Common Stock 2.67K $2.55 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The number of shares beneficially owned reflects the 1-for-15 reverse stock split effected August 26, 2022.
F2 The per share exercise price and number of shares subject to the option reflect the 1-for-5 reverse stock split effected October 15, 2017 and the 1-for-15 reverse stock split effected August 26, 2022.
F3 All of the shares subject to this option are fully vested and exercisable as of the date hereof.
F4 The per share exercise price and number of shares subject to the option reflect the 1-for-15 reverse stock split effected August 26, 2022.
F5 The shares subject to the Option shall vest on the earlier of the twelve-month anniversary of June 1, 2022 or the day before the next annual stockholder meeting, subject to Reporting Person continuing to be a Service Provider through each such date.